Verve Therapeutics Inc (VERV)
4.65
+0.10
(+2.20%)
USD |
NASDAQ |
Nov 21, 15:23
Verve Therapeutics Price to Book Value: 0.7741 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 0.7575 |
| November 19, 2024 | 0.8058 |
| November 18, 2024 | 0.7492 |
| November 15, 2024 | 0.7974 |
| November 14, 2024 | 0.8957 |
| November 13, 2024 | 0.9639 |
| November 12, 2024 | 1.067 |
| November 11, 2024 | 1.069 |
| November 08, 2024 | 1.050 |
| November 07, 2024 | 1.059 |
| November 06, 2024 | 1.067 |
| November 05, 2024 | 1.062 |
| November 04, 2024 | 1.007 |
| November 01, 2024 | 0.9872 |
| October 31, 2024 | 0.9539 |
| October 30, 2024 | 0.9639 |
| October 29, 2024 | 0.9972 |
| October 28, 2024 | 0.9886 |
| October 25, 2024 | 0.9936 |
| October 24, 2024 | 0.952 |
| October 23, 2024 | 0.922 |
| October 22, 2024 | 0.947 |
| October 21, 2024 | 0.9237 |
| October 18, 2024 | 0.9403 |
| October 17, 2024 | 0.9087 |
| Date | Value |
|---|---|
| October 16, 2024 | 0.932 |
| October 15, 2024 | 0.9304 |
| October 14, 2024 | 0.8371 |
| October 11, 2024 | 0.7772 |
| October 10, 2024 | 0.7656 |
| October 09, 2024 | 0.7606 |
| October 08, 2024 | 0.7523 |
| October 07, 2024 | 0.7972 |
| October 04, 2024 | 0.8322 |
| October 03, 2024 | 0.7856 |
| October 02, 2024 | 0.7989 |
| October 01, 2024 | 0.7972 |
| September 30, 2024 | 0.8055 |
| September 27, 2024 | 0.7717 |
| September 26, 2024 | 0.7686 |
| September 25, 2024 | 0.7392 |
| September 24, 2024 | 0.7671 |
| September 23, 2024 | 0.7779 |
| September 20, 2024 | 0.8043 |
| September 19, 2024 | 0.8337 |
| September 18, 2024 | 0.8538 |
| September 17, 2024 | 0.8353 |
| September 16, 2024 | 0.8399 |
| September 13, 2024 | 0.8523 |
| September 12, 2024 | 0.8755 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6818
Minimum
Aug 14 2024
8.759
Maximum
Sep 10 2021
2.959
Average
2.238
Median
Price to Book Value Benchmarks
| Ardelyx Inc | 7.736 |
| Biomarin Pharmaceutical Inc | 2.240 |
| Sage Therapeutics Inc | 0.5565 |
| ALX Oncology Holdings Inc | 0.4973 |
| Immuneering Corp | 1.157 |
Price to Book Value Related Metrics
| PS Ratio | 15.91 |
| Price | 4.65 |
| Earnings Yield | -52.90% |
| Market Cap | 393.69M |